NYC Healthcare Venture Capital Report 2019


It’s here! The second annual New York City Healthcare Venture Capital Report 2019, an in-depth analysis of the companies, investors and trends driving healthcare investment in New York. In 2019, we saw $1.85 billion invested across 83 healthcare companies. Like the rest of the industry, we saw larger rounds at all stages. Our report breaks down the numbers by total financings, sector and round, and includes a ranking of the top 25 funded health companies, top investors to know and six trends to watch in 2019.

One of the factors that differentiates NYC from other markets is the entrepreneurs, investors and advisors who are driving innovation within our health ecosystem. We have included insights and expertise from 15 of NYC’s leading movers and shakers this year:

  • Gil Addo – CEO, RubiconMD

  • Michael Aberman, MD – CEO, Quentis Therapeutics

  • Jean Drouin, MD –CEO, Clarify Health

  • Wendy Goldstein, Esq. – Partner, Cooley

  • Carolyn Magill – CEO, Aetion

  • Ezra Mehlman – General Partner, Health Enterprise Partners

  • Florian Otto, MD – CEO, Cedar

  • Yvan-Claude Pierre, Esq. – Partner, Cooley

  • Todd Pietri – Managing Partner, Activate Venture Partners

  • Zachariah Reitano – CoFounder and CEO, Ro

  • Aran Ron, MD – Partner, FundRx

  • Drew Schiff, MD – Managing Partner, Aisling Capital

  • Bronwyn Spira, PT – CEO, Force Therapeutics

  • Ellie Wheeler – Partner, Greycroft

  • Joel Wishkovsky – CEO, Simple Contacts

Let us know what you think - what stands out? Email me at